Clinical Trial Authorisations

MHRA Post-Transition Period Information

MHRA Post-Transition Period Information

Clinical Trial Authorisations (CTA) - December 2020 Our Regulatory Affairs Team focus on the important information you need, as we approach the end of the BREXIT transition period. How will Brexit impact my clinical trial? MHRA has published several updates…
MHRA Submissions – The UK submissions portal from 01 January 2021

MHRA Submissions – The UK submissions portal from 01 January 2021

Following the end of the Brexit transition period in January, submissions relating to Clinical Trial Authorisations and Marketing Authorisations in the UK will need to be submitted via MHRA Submissions Portal, not CESP. MHRA Submissions First Step The first step…